サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631481

冠動脈ステントの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2025年～2030年

Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents (BMS), Drug Eluting Stents (DES), Bioresorbable Vascular Scaffold), By End Use (Inpatient and Outpatient Facilities), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.11円
冠動脈ステントの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年12月19日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

冠動脈ステント市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の冠動脈ステント市場規模は2030年までに97億米ドルに達する見込みです。

同市場は2025～2030年にかけてCAGR 2.6％で拡大する見込みです。低侵襲手術や経皮的冠動脈インターベンション（PCI）手技の採用が増加していることが、今後数年間の市場を牽引すると予想されています。例えば、The Korean Journal of Thoracic and Cardiovascular Surgeryによると、2016年の冠動脈疾患（CAD）に対するPCIの割合は78％、国によるPCI割合は96％で、世界平均を大きく上回っています。その結果、CAD罹患率のかつてない増加とともに、これらのCAD患者に対して行われるPCIの割合が増加し、効果的な冠動脈ステント技術に対する需要が高まると予想されます。

技術の進歩と第2世代の薬剤溶出ステントの発売が、さらに成長を促進しています。例えば、Abbott Laboratories LaboratoriesのXIENCE Sierraは、2018年5月に米国でCTO適応で承認された最初のDESとなりました。Medtronicも2019年初めにこれに続き、CTO適応における同社のResoluteシリーズのDESの使用についてFDAの承認を取得しました。さらに、多くの企業が最近米国で冠動脈ステントシステムの新バージョンを発売しており、特にBoston ScientificのSynergy Megatronは2021年1月に、Abbott LaboratoriesのXIENCE Skypointは2021年6月に発売されました。

COVID-19の世界的大流行は冠動脈ステント市場に悪影響を与えました。世界中の医師会のガイドラインによると、手技の延期は主に適格な患者に対する緊急性の低い手技や選択的な手技に影響を与えました。例えばACC（米国心臓病学会）の2020年ガイダンスでは、COVID-19流行のピーク時にはCTOインターベンションやサーベイランス血管造影のような緊急性のない手技の延期を推奨していました。これらのガイドラインは世界中の医師の治療決定に影響を与えています。さらに、欧州心臓病学会の勧告によると、すべての緊急と緊急PCI手技（STEMI、高リスクまたは中リスクのNSTEMI、心原性ショック、不安定狭心症の治療）は、パンデミックのピーク時とその後のCOVID-19の再流行時にも継続されるべきであり、一方、選択的PCI手技（CTOインターベンションまたはNYHA II症状の治療）のみ延期されるべきです。

さらに、COVID-19パンデミックからの冠動脈ステント市場の回復は、緊急PCI手技の継続的な実施と非選択的手技を実施するための稼働率の上昇によって助長されると予想されます。

冠動脈ステント市場は、公的なメディケア＆メディケイドサービスセンター（CMS）と民間支払機関が提供する償還保険によって牽引されています。頸動脈ステント留置術の保険適用範囲は、製品やサービスプロバイダーを含む全国的な保険適用範囲決定に基づいています。2020年1月以降、メディケア＆メディケイドサービスセンター（CMS）は、外来手術センター（ASC）で実施される一部の血管形成術とステント留置術に対する償還を提案し、予測期間中の市場収益を押し上げることが期待されます。

冠動脈ステント市場レポートハイライト

  • 冠動脈ステントデバイスで治療されるPCI手技全体の件数は、高齢化とPCI適格患者数の増加に伴い、新技術と重症病変の治療能力の向上により増加します。
  • 生体吸収性血管骨格は、冠動脈疾患の治療において、患者の心臓に一時的に留置されること、3年で分解されるため将来の治療が容易であること、患者の体内で完全に溶解することなど、いくつかの利点があるため、2番目に急成長するセグメントと予想されます。
  • DESが標準的なBMSよりも優れていることは、良好な臨床検査によって証明されています。その結果、2021年にはDESが市場を独占しています。
  • 北米は冠動脈ステント市場を独占し、2024年には43.6%の最大収益シェアを占めました。
  • 冠動脈ステントのアジア太平洋市場は、収益創出という点で最も速い成長率を示すと予想されています。この市場は、CADのスクリーニング強化、経済成長、規制の更新、オーストラリアや韓国のような一部の国における注目すべき有益な償還などの追加変数によって牽引されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 冠動脈ステント市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 冠動脈ステント市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 冠動脈ステント市場：製品別、推定・動向分析

  • 世界の冠動脈ステント市場：製品ダッシュボード
  • 世界の冠動脈ステント市場：製品変動分析
  • 製品別、収益
  • ベアメタルステント
  • 薬剤溶出ステント
  • 生体吸収性血管スキャフォールド（BVS）/生体吸収性冠動脈ステント

第5章 冠動脈ステント市場：最終用途別、推定・動向分析

  • 世界の冠動脈ステント市場：最終用途ダッシュボード
  • 世界の冠動脈ステント市場：最終用途変動分析
  • 最終用途別、収益
  • 入院施設
  • 外来施設

第6章 冠動脈ステント市場：製品と最終用途による地域別、推定・動向分析

  • 地域ダッシュボード
  • 市場規模と予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業の市場シェア分析、2024年
    • Abbott
    • Medtronic
    • Boston Scientific Corporation
    • Terumo Corporation
    • B Braun SE
    • BIoTronik.
    • Stentys SA
    • MicroPort Scientific Corporation
    • CR Bard, Inc.
    • Cook Medical
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 10 Mexico coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 12 Europe coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 14 Germany coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 15 UK coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 16 UK coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 17 France coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 18 France coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Italy coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 20 Italy coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Spain coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 22 Spain coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Denmark coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 24 Denmark coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Sweden coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 26 Sweden coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Norway coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 28 Norway coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 32 China coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 33 China coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Japan coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 35 Japan coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 36 India coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 37 India coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 38 South Korea coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 39 South Korea coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Australia coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 41 Australia coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Thailand coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 43 Thailand coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Latin America coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 45 Latin America coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 46 Latin America coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Brazil coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 48 Brazil coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Argentina coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 50 Argentina coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 51 MEA coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 52 MEA coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 53 MEA coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 54 South Africa coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 55 South Africa coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 58 UAE coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 59 UAE coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Kuwait coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 61 Kuwait coronary stents market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Coronary stents market: market outlook
  • Fig. 7 Coronary stents competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Coronary stents market driver impact
  • Fig. 11 Coronary stents market restraint impact
  • Fig. 12 Coronary stents market: Product movement analysis
  • Fig. 13 Coronary stents market: Product outlook and key takeaways
  • Fig. 14 Bare metal stents coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Drug eluting stents coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Bioresorbable vascular scaffolds (BVS)/bioresorbable coronary stents coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Coronary stents market: End Use movement analysis
  • Fig. 18 Coronary stents market: End Use outlook and key takeaways
  • Fig. 19 Inpatient facilities coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Outpatient facilities coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Global coronary stents market: Regional movement analysis
  • Fig. 22 Global coronary stents market: Regional outlook and key takeaways
  • Fig. 23 Global coronary stents market share and leading players
  • Fig. 24 North America, by country
  • Fig. 25 North America coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. key country dynamics
  • Fig. 27 U.S. coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada key country dynamics
  • Fig. 29 Canada coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Mexico key country dynamics
  • Fig. 31 Mexico coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 UK key country dynamics
  • Fig. 34 UK coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany key country dynamics
  • Fig. 36 Germany coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France key country dynamics
  • Fig. 38 France coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy key country dynamics
  • Fig. 40 Italy coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain key country dynamics
  • Fig. 42 Spain coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark key country dynamics
  • Fig. 44 Denmark coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden key country dynamics
  • Fig. 46 Sweden coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Norway key country dynamics
  • Fig. 48 Norway coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 China key country dynamics
  • Fig. 51 China coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Japan key country dynamics
  • Fig. 53 Japan coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 India key country dynamics
  • Fig. 55 India coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand key country dynamics
  • Fig. 57 Thailand coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea key country dynamics
  • Fig. 59 South Korea coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia key country dynamics
  • Fig. 61 Australia coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil key country dynamics
  • Fig. 64 Brazil coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina key country dynamics
  • Fig. 66 Argentina coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Middle East and Africa coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa key country dynamics
  • Fig. 69 South Africa coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia key country dynamics
  • Fig. 71 Saudi Arabia coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 UAE key country dynamics
  • Fig. 73 UAE coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait key country dynamics
  • Fig. 75 Kuwait coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Market share of key market players- Coronary stents market
目次
Product Code: GVR-1-68038-106-1

Coronary Stents Market Growth & Trends:

The global coronary stents market size is expected to reach USD 9.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.6% from 2025 to 2030. Increasing adoption of minimally invasive surgeries and Percutaneous Coronary Intervention (PCI) procedures is expected to drive the market in the coming years. For instance, according to The Korean Journal of Thoracic and Cardiovascular Surgery, the proportion of PCI for Coronary Artery Disease (CAD) was 78% in 2016, and the country-specific PCI proportion was 96%, which was significantly higher than the global average. As a result, the unprecedented growth in CAD incidence, along with an increase in the proportion of PCIs done in these CAD patients, is expected to raise demand for an effective coronary stent technology.

Technological advancement and the launch of 2nd generation drug-eluting stents are further fueling the growth. For instance, Abbott Laboratories Laboratories' XIENCE Sierra became the first DES approved for CTO indications in the US in May 2018. Medtronic followed suit in early 2019, obtaining FDA approval for the use of its Resolute range of DES in CTO indications. In addition, many companies have recently launched newer versions of their coronary stent systems in the US, notably Boston Scientific's Synergy Megatron in January 2021 and Abbott Laboratories Laboratories' XIENCE Skypoint in June 2021.

The global COVID-19 pandemic has had a negative impact on the market for coronary stents. According to guidelines from physician societies throughout the world, procedure deferrals primarily impacted less urgent or elective procedures for eligible patients. ACC's ((American College of Cardiology) 2020 guidance, for instance, recommended postponing non-urgent procedures like CTO interventions and surveillance angiography during the peak of the COVID-19 pandemic. These guidelines have influenced physicians' treatment decisions throughout the world. Additionally, according to the European Society of Cardiology recommendations, all emergency and urgent PCI procedures (treatment of STEMI, high or intermediate risk NSTEMI, cardiogenic shock, and unstable angina) should be continued during the peak of the pandemic and in the subsequent resurgence of COVID-19, while only elective PCI procedures (CTO interventions or treatment of NYHA II symptoms) should be deferred.

Moreover, recovery of the coronary stent market from the COVID-19 pandemic is anticipated to be aided by the continuous performance of urgent PCI procedures and an increase in capacity utilization for performing non-elective procedures.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare & Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service providers. From January 2020, the Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in the ambulatory surgical centers (ASC), which is expected to boost the market revenue over the forecast period.

Coronary Stents Market Report Highlights:

  • Overall PCI procedure volumes treated with coronary stent devices will rise as the aging population and the PCI-eligible patient population grows, owing to new technologies and increased ability to treat severe lesions
  • The bioresorbable vascular scaffold segment is expected to be the second fastest growing segment due to its several advantages in treating coronary artery disease including temporary placement in the patient heart, ease for future treatments as it degrades over 3 years, and it dissolve completely in the patient body.
  • Favorable clinical trials have demonstrated that DES is better than standard BMS. As a result, in 2021, DES has dominated the market
  • North America dominated the coronary stents market and accounted for the largest revenue share of 43.6% in 2024 and is anticipated to witness the same trend over the foreseeable future.
  • The Asia Pacific market for coronary stents is expected to exhibit the fastest growth rate in terms of revenue generation. This market is driven by some additional variables of enhanced screening for CAD, economic growth, regulatory updates, and notable beneficial reimbursement in some countries such as Australia and South Korea.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Coronary Stents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cardiovascular diseases
      • 3.2.1.2. Technological advancements in stent designs
      • 3.2.1.3. Increasing healthcare access and awareness
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced stents
      • 3.2.2.2. Risk of complications and side effects
  • 3.3. Coronary Stents Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Coronary Stents Market: Product Estimates & Trend Analysis

  • 4.1. Global Coronary Stents Market: Product Dashboard
  • 4.2. Global Coronary Stents Market: Product Movement Analysis
  • 4.3. Global Coronary Stents Market by Product, Revenue
  • 4.4. Bare Metal Stents
    • 4.4.1. Bare metal stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Drug Eluting Stents
    • 4.5.1. Drug eluting stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Bioresorbable Vascular Scaffolds (BVS)/Bioresorbable Coronary Stents
    • 4.6.1. Bioresorbable vascular scaffolds (BVS)/bioresorbable coronary stents market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Coronary Stents Market: End Use Estimates & Trend Analysis

  • 5.1. Global Coronary Stents Market: End Use Dashboard
  • 5.2. Global Coronary Stents Market: End Use Movement Analysis
  • 5.3. Global Coronary Stents Market Estimates and Forecasts, by End Use, Revenue (USD Million)
  • 5.4. Inpatient Facilities
    • 5.4.1. Inpatient facilities market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Outpatient Facilities
    • 5.5.1. Outpatient facilities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Coronary Stents Market: Regional Estimates & Trend Analysis by Product and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait coronary stents market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Vendor Landscape
    • 7.2.1. Key company market share analysis, 2024
    • 7.2.2. Abbott
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Medtronic
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Boston Scientific Corporation
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Terumo Corporation
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. B Braun SE
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Biotronik.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Stentys SA
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. MicroPort Scientific Corporation
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. C.R. Bard, Inc.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Cook Medical
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives